Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710901 · ClinicalTrials.gov registry record · NA
UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 388
- Enrollment target
NCT04710901 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 388 participants.
The verdict
NCT04710901, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 388 participants
- Enrollment target
Study Summary
This project seeks to develop and test the acceptability, appropriateness and feasibility of uTECH, a novel social media "big data" machine learning intervention for HIV-negative substance-using sexual and gender minority people who have sex with men that aims to reduce HIV transmission risk by integrating biomedical and behavioral risk reduction strategies, including pre-exposure prophylaxis (PrEP) for HIV prevention and medication assisted treatment (MAT) for substance use harm reduction
Interventions
- BEHAVIORAL uTECH + YMHP
- BEHAVIORAL YMHP
- BEHAVIORAL uTECH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04710901
The ClinicalTrials.gov registry entry for NCT04710901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which uTECH + YMHP is the first listed.
NCT04710901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04710901 about?
NCT04710901 is a clinical study titled "UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM". This project seeks to develop and test the acceptability, appropriateness and feasibility of uTECH, a novel social media "big data" machine learning intervention for HIV-negative substance-using sexual and gender minority people who have sex with men that aims to reduce HIV transmission risk by inte...
What is the current status of trial NCT04710901?
This trial is currently completed. It is a NA study. The enrollment target is 388 participants. The study started on 2020-11-24. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT04710901?
The interventions under investigation include: uTECH + YMHP (BEHAVIORAL), YMHP (BEHAVIORAL), uTECH (BEHAVIORAL).
Who is sponsoring clinical trial NCT04710901?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.